Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy
Cutaneous squamous cell carcinomas (SCCs) are a major complication of some subtypes of epidermolysis bullosa (EB), with high morbidity and mortality rates and unmet therapeutic needs. The high rate of endogenous mutations and the fibrotic stroma are considered to contribute to the pathogenesis. Pati...
Main Authors: | David Rafei-Shamsabadi, Lena Scholten, Sisi Lu, Daniele Castiglia, Giovanna Zambruno, Andreas Volz, Andreas Arnold, Mina Saleva, Ludovic Martin, Kristin Technau-Hafsi, Frank Meiss, Dagmar von Bubnoff, Cristina Has |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/2/471 |
Similar Items
-
Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
by: Laura Trefzer, et al.
Published: (2023-06-01) -
“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires
by: May El Hachem, et al.
Published: (2024-04-01) -
Epidermolysis bullosa pruriginosa
by: Puri Suruchi, et al.
Published: (2005-01-01) -
Pretibial dystrophic epidermolysis bullosa
by: Elisabeth de Albuquerque Cavalcanti Callegaro, et al.
Published: (2017-01-01) -
Dystrophic epidermolysis bullosa in a child
by: Uma Eswara
Published: (2012-01-01)